These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 35107865

  • 1. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
    Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P, Barua I, Jodal HC, Melum E, Løberg M, Blom J, Bretthauer M, Adami HO, Kalager M, Ye W.
    United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
    [Abstract] [Full Text] [Related]

  • 2. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P, Karvonen AL, Laukkarinen J, Aitola P, Huhtala H, Collin P.
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [Abstract] [Full Text] [Related]

  • 3. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies.
    Fung BM, Lindor KD, Tabibian JH.
    World J Gastroenterol; 2019 Feb 14; 25(6):659-671. PubMed ID: 30783370
    [Abstract] [Full Text] [Related]

  • 4. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, Gutiérrez A, Gordillo Ábalos J, de Castro L, Iborra M, Carbajo AY, Taxonera C, Rodríguez-Lago I, Mesonero F, de Francisco R, Gómez-Gómez GJ, Chaparro M, Tardillo CA, Rivero M, Algaba A, Martín Arranz E, Cañete F, Vicente R, Sicilia B, Antolín B, Prieto V, Márquez L, Benítez JM, Camo P, Piqueras M, Gargallo CJ, Hinojosa E, Huguet JM, Pérez Calle JL, Van Domselaar M, Rodriguez C, Calvet X, Muñoz-Villafranca C, García-Sepulcre MF, Munoz-Garrido P, Fernández-Clotet A, Gómez Irwin L, Hernández S, Guardiola J, Sempere L, González Muñoza C, Hernández V, Beltrán B, Barrio J, Alba C, Moraleja I, López-Sanromán A, Riestra S, Martínez Montiel P, Garre A, Arranz L, García MJ, Martín Arranz MD, Corsino P, Arias L, Fernández-Salazar L, Fernández-Pordomingo A, Andreu M, Iglesias E, Ber Y, Mena R, Arroyo Villarino MT, Mora M, Ruiz L, López-Serrano P, Blazquez I, Villoria A, Fernández M, Bermejo F, Banales JM, Domènech E, Gisbert JP, Spanish GETECCU group (ENEIDA Project).
    J Crohns Colitis; 2019 Dec 10; 13(12):1492-1500. PubMed ID: 31063540
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.
    Huang J, Li X, Hong J, Huang L, Jiang Q, Guo S, Rong Y, Guo G.
    Cancer Med; 2023 Jun 10; 12(12):13599-13609. PubMed ID: 37184160
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Screening for malignancy in primary sclerosing cholangitis (PSC).
    Khaderi SA, Sussman NL.
    Curr Gastroenterol Rep; 2015 Apr 10; 17(4):17. PubMed ID: 25786901
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW.
    Ann Surg; 1997 May 10; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [Abstract] [Full Text] [Related]

  • 14. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
    Ehlken H, Schramm C.
    Dig Dis; 2013 May 10; 31(1):118-25. PubMed ID: 23797133
    [Abstract] [Full Text] [Related]

  • 15. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A, Glaumann H, Persson B, Broomé U.
    Hepatology; 1998 Feb 10; 27(2):311-6. PubMed ID: 9462625
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat.
    Bonato G, Cristoferi L, Strazzabosco M, Fabris L.
    Dig Dis; 2015 Feb 10; 33 Suppl 2(Suppl 2):140-8. PubMed ID: 26641079
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Loftus EV.
    Hepatol Int; 2020 Dec 10; 14(6):1114-1124. PubMed ID: 33369708
    [Abstract] [Full Text] [Related]

  • 20. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
    Nair AV, Macdonald DB, Kelly EM, Satheesh S, Venugopalan P, Soman DK.
    Clin Imaging; 2022 Jan 10; 81():47-53. PubMed ID: 34598005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.